3% Sodium Chloride

FDA Drug Profile — 3% Sodium Chloride

Drug Details

Generic Name
3% Sodium Chloride
Brand Names
3% Sodium Chloride
Application Number
ANDA209476
Sponsor
Becton Dickinson and Company
NDC Codes
1
Dosage Forms
INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients
SODIUM CHLORIDE

Indications and Usage

1 INDICATIONS & USAGE GaviLyte - H and bisacodyl delayed-release tablet, USP is indicated for cleansing of the colon as a preparation for colonoscopy in adults. GaviLyte - H and bisacodyl delayed-release tablet, USP is a combination of PEG-3350, an osmotic laxative and bisacodyl, a stimulant laxative, indicated for cleansing of the colon as a preparation for colonoscopy in adults ( 1 )